A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(6 sites)

United States

California Clinical Trials Medical Group, Glendale, California

Velocity Clinical research, Los Angeles, California

Genoma Research Group, Inc, Miami, Florida

Med Research of Florida, LLC, Miami, Florida

Tandem Clinical Research, Marrero, Louisiana

Pioneer Research Solutions, Houston, Texas